TGFB1 and neoplasm: As mentioned in earlier sections, further investigation within these prognostic stromal gene signatures identified a prominence of TGF‐beta target genes expressed by CAFs in the most aggressive tumours, which are promising poor‐prognosis biomarkers that can be assessed using either transcriptomic or immunohistochemical techniques (Calon et al., 2012, 2015).